Trials / Completed
CompletedNCT00117325
Study Of Adults And Adolescents With Vasomotor Rhinitis
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 352 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with vasomotor rhinitis (VMR).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GW685698X | Aqueous Nasal Spray 100mcg |
Timeline
- Start date
- 2005-07-11
- Primary completion
- 2006-02-09
- Completion
- 2006-02-09
- First posted
- 2005-07-06
- Last updated
- 2018-03-13
- Results posted
- 2018-03-13
Locations
53 sites across 6 countries: United States, Canada, Czechia, Germany, Norway, Romania
Source: ClinicalTrials.gov record NCT00117325. Inclusion in this directory is not an endorsement.